Inventor · disambiguated record
Tomoya Machinami
Also filed as: MACHINAMI TOMOYA
11 granted patents·154 citations·filing 1975–1993
90Inventor score
Top patents by PatentIndex Score
11 records- 0192US5399566APyridine derivatives having angiotensin II antagonismMEIJI SEIKA CO·Filed 1991·Granted Mar 21, 1995·69 cites·11 claims
- 0279US4086415ANitrosourea derivatives of glycosidesSUAMI T·Filed 1975·Granted Apr 25, 1978·16 cites·7 claims
- 0377US5190952A4-acyloxyquinoline derivatives and insecticidal or acaricidal compositions containing sameMEIJI SEIKA CO·Filed 1990·Granted Mar 2, 1993·25 cites·7 claims
- 0473US5294629ABenzothiazole and benzimidazole derivatives and antiulcer agent containing the sameMEIJI SEIKA KAISHA·Filed 1993·Granted Mar 15, 1994·17 cites·7 claims
- 0570US5194617A2,3-disubstituted-4-hydroxyquinoline derivativesMEIJI SEIKA KAISHA·Filed 1991·Granted Mar 16, 1993·11 cites·1 claims
- 0652US4180655ANitrosourea derivativesHISAMATSU TAKASHI·Filed 1978·Granted Dec 25, 1979·6 cites·5 claims
- 0740US5185347APiperidine compounds and antiulcer composition containing the sameMEIJI SEIKA KAISHA·Filed 1991·Granted Feb 9, 1993·2 cites·10 claims
- 0840US5141946AAzole derivatives and anti-ulcerative composition containing sameMEIJI SEIKA CO·Filed 1991·Granted Aug 25, 1992·4 cites·4 claims
- 0934US5200407AAzole derivatives and anti-ulcerative composition containing sameMEIJI SEIKA KABURHIKI KAISHA·Filed 1991·Granted Apr 6, 1993·2 cites·5 claims
- 1033US5171746AThiazole and imidazole derivatives and antiulcer composition containing sameMEIJI SEIKA CO·Filed 1991·Granted Dec 15, 1992·1 cites·7 claims
- 1132US4889926AMethod for the synthesis of (2"R)-4'-O-tetra-hydropyranyladriamycim using 14-chloro-daunomycin as an intermediateZAIDAN HOJIN BISEIBUTSU·Filed 1988·Granted Dec 26, 1989·1 cites·7 claims
Join the waitlist — get patent alerts
Get an alert when Tomoya Machinami files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →